Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease
Although only a small fraction will ever develop the active form of tuberculosis (ATB) disease, chemoprophylaxis treatment in latent TB infected (LTBI) individuals is an effective strategy to control pathogen transmission. Characterizing immune responses in LTBI upon chemoprophylactic treatment is i...
Główni autorzy: | Burel, JG, Singhania, A, Dubelko, P, Muller, J, Tanner, R, Parizotto, E, Dedicoat, M, Fletcher, TE, Dunbar, J, Cunningham, AF, Lindestam Arlehamn, CS, Catanzaro, DG, Catanzaro, A, Rodwell, T, McShane, H, O'Shea, MK, Peters, B |
---|---|
Format: | Journal article |
Język: | English |
Wydane: |
Elsevier
2021
|
Podobne zapisy
-
Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants
od: O'Shea, M, i wsp.
Wydane: (2014) -
Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
od: Matthew K O'Shea, i wsp.
Wydane: (2014-01-01) -
Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
od: O'Shea, M, i wsp.
Wydane: (2018) -
In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
od: Mcshane, H, i wsp.
Wydane: (2017) -
Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.
od: Elisea Avalos, i wsp.
Wydane: (2015-01-01)